홈MCP워크벤치Skills
홈워크벤치알림마이페이지
Huagongshe 오픈 프로젝트:[email protected]AI 접속: llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.7.9
  1. 홈
  2. /화합물

철 덱스트란 착화합물

Iron-dextran

HCID 178926435
새 노트새 반응견적 요청하기인쇄 미리보기
기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
9004-66-4
표준 SMILES
O=S(=O)(O)O.[Fe]
InChIKey
MVZXTUSAYBWAAM-UHFFFAOYSA-N
분자식
FeH2O4S
평균 분자량
153.9235 g/mol

이름 및 식별자

우선 이름
Iron-dextran
현지명
철 덱스트란 착화합물
영어명
Iron-dextran
분자식
FeH2O4S
분자량
153.92348

이름 및 동의어

철덱스트란착화합물철덱스트란착화합물(IRONDEXTRANCOMPLEX)철-덱스트란IRON DEXTRANIron dextran solutiona100INFeDDexferruMb75fe-dextranDextran ironfenate
이름 더 보기
Dexfer

데이터베이스 식별자

CAS
9004-66-4

물성

물리화학적 성질

저장 조건
Room Temperature
용해도
물(약간 용해됨)
물리적 상태
액체
색상
매우 어두운 빨간색에서 검정색까지
수소이온지수(pH)
4 · 4 - 6.5
생물학적 소스
synthetic
수용성
100 mg/mL · Iron, ~100mg/mL in water
InChI
InChI=1S/Fe.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)
InChIKey
MVZXTUSAYBWAAM-UHFFFAOYSA-N
SMILES
[Fe].S(=O)(=O)(O[H])O[H]
EPA
Iron dextran (9004-66-4)

화학적 성질

Light to dark brown powder. Colloidal suspension of an iron-dextran complex in water. pH 5.2-6.5.

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

안전 데이터

wgk
-
rtecs
NI2200000
독성
LD50 i.v. in mice: 2240 mg Fe/kg (Beliles)
risk_code
40-42/43-43-45
hazard_code
Xn,T
safety_code
23-26-36/37/39-45-36-36/37-53
Hazard Classifications
Carc. 1BSkin Sens. 1
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
유해 물질 데이터
9004-66-4(Hazardous Substances Data)

화학 및 산업

응용 분야 · 3건

개요Iron dextran is a dark brown, slightly viscous liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. Iron Dextran is used for the treatment of patients with documented iron deficiency in which oral administration is unsatisfactory or impossible. It is supplied as a parenteral preparation and is used as a hematinic. (Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1292) Iron-Dextran is for the parenteral treatment of iron-deficiency anemia in humans and baby pigs. Can be used as a reagent.

역사The therapeutic value of colloidal iron preparations was first reported in the 1950's by London and Twigg. Numerous attempts have been made to improve these iron preparations Thus dextran ([h] 0.05) is first heated with alkali, and is then neutralized in the presence of ferric chloride solution. Studies on this product have revealed that each particle consists of a central iron core, approximately 3nm diameter, surrounded by a dextran sheath of approximately 13nm diameter. The complex is visualized as a particle formed by a protective sheath of dextran attached by terminal metasaccharinic acid units to a b-FeOOH core. A solution of this complex containing 5% iron and 20% dextran (Imferon ™ ) is suitable for intramuscular and intravenous injection for treating iron deficiency anemia. The product is currently used widely for treating anemia in new-born piglets. The use of these preparations has been re-examined in humans and a dramatic rise in hemoglobin was reported following intravenous infusion. The solution is best administered together with glucose solutions.

용도Iron-Dextran (ferric hydroxide dextran complex) may be used as an intravenous iron delivery preparation. Iron-Dextran may be used to induce iron-overload to study its effects and preventative measures.

상·하류 제품 정보

하류 제품

덱스트란

공급사

불러오는 중…

공개 문의

불러오는 중…

관련 반응

0건
반응 기록 만들기

현재 필터 조건에 해당하는 반응 기록이 없습니다.

화합물 노트

불러오는 중…

이 페이지에서기본 정보이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트